Company intelligence / Profile preview

Ekkyo

Ownership: Private
Development stage: Other

Overview

Ekkyo developed a first-in-class handheld laser system (“Ekkylite™”) designed to prevent and reduce surgical scars by applying controlled selective hyperthermia at the time of wound closure. A pilot clinical trial in humans demonstrated safety and encouraging efficacy for cosmetic improvement after abdominoplasty.

Therapeutic areas: Dermatology
Modalities: DeviceLaser-based therapy
Industry: Therapeutic Medical Devices

Partnerships

Lille University Hospital Center (clinical study site/partner)

Beyond the preview

Go deeper on Ekkyo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ekkyo.

Explore the full profile